Light Mode
$0.0000 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0000, and at the day’s high of $0.0000
-0.00 (+0.00%) / 6M
Momentum, market sentiment, and recent alerts
BTTX reads n/a: the 12-month move is -100.0%.
No alerts for BTTX in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Better Therapeutics, Inc. operates as a digital therapeutics company, which engages in developing a novel form of cognitive behavioral therapy to address the root causes of cardio metabolic diseases. It offers software-based solutions for type 2 diabetes, heart disease and other conditions. The company was founded by Kevin J. Appelbaum and David P. Perry in April 2015 and is headquartered in San Francisco, CA.
No peer group available for this symbol.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.